Immediate Impact
2 from Science/Nature 70 standout
Citing Papers
A comprehensive spatio-cellular map of the human hypothalamus
2025 StandoutNature
Obesity in adults
2024 Standout
Works of Robert S. Mittleman being referenced
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
2022
ODP606 Long-term Efficacy of Setmelanotide in Patients With Bardet-Biedl Syndrome
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert S. Mittleman | 512 | 211 | 119 | 40 | 820 | |
| Tetsuro Yoshida | 503 | 140 | 171 | 41 | 924 | |
| Xueqi Li | 380 | 264 | 153 | 42 | 729 | |
| Mario Pacileo | 391 | 137 | 138 | 31 | 853 | |
| Sabine Fredersdorf | 477 | 102 | 128 | 38 | 718 | |
| Yoshitane Seino | 387 | 198 | 201 | 26 | 849 | |
| Latonya Been | 484 | 306 | 127 | 35 | 793 | |
| Elaine J. Tanhehco | 426 | 187 | 193 | 29 | 817 | |
| Akinobu Maeda | 421 | 109 | 184 | 36 | 741 | |
| Rosemeire M. Kanashiro‐Takeuchi | 409 | 196 | 424 | 40 | 926 | |
| Kazuyuki Sakata | 499 | 164 | 61 | 45 | 803 |
All Works
Login with ORCID to disown or claim papers
Loading papers...